From memory, the THI are also involved in research in improving...

From memory, the THI are also involved in research in improving the LVAD, so there’s an added angle to any success that may come of the company’s effort in advancing Revascor for LVAD end stage heart failure patients. The company intends to pursue AA for such patients in 2025, to then be supported by a confirmatory trial which Dr. Perin said in public will be designed and run in such a way to provide high confidence of achieving its primary endpoint - effectively by garnering the substantial insights that came out of the DREAM-HF trial. He is also on the record to say that his heart failure research would be a 25 year effort by the time they managed to get regulatory approval. Even shareholders sometimes forget how close they are to being rewarded for such gigantic effort and time in research. Covid taught the world the value of good science, of telling the truth, and that failure is the mother of all success.